Atıf Formatları
The usage of the immunosuppressant agents and secondary infections in patients with COVID‑19 in intensive care unit: a retrospective study
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Z. T. Sarıkaya Et Al. , "The usage of the immunosuppressant agents and secondary infections in patients with COVID‑19 in intensive care unit: a retrospective study," 41st International Symposium on Intensive Care and Emergency Medicine , Brussels, Belgium, pp.38-39, 2022

Sarıkaya, Z. T. Et Al. 2022. The usage of the immunosuppressant agents and secondary infections in patients with COVID‑19 in intensive care unit: a retrospective study. 41st International Symposium on Intensive Care and Emergency Medicine , (Brussels, Belgium), 38-39.

Sarıkaya, Z. T., Güçyetmez, B., Tüzüner, F., Dinçer, Ö., Şahan, C., Telci, L., ... Akıncı, İ. Ö.(2022). The usage of the immunosuppressant agents and secondary infections in patients with COVID‑19 in intensive care unit: a retrospective study . 41st International Symposium on Intensive Care and Emergency Medicine (pp.38-39). Brussels, Belgium

Sarıkaya, Zeynep Et Al. "The usage of the immunosuppressant agents and secondary infections in patients with COVID‑19 in intensive care unit: a retrospective study," 41st International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium, 2022

Sarıkaya, Zeynep T. Et Al. "The usage of the immunosuppressant agents and secondary infections in patients with COVID‑19 in intensive care unit: a retrospective study." 41st International Symposium on Intensive Care and Emergency Medicine , Brussels, Belgium, pp.38-39, 2022

Sarıkaya, Z. T. Et Al. (2022) . "The usage of the immunosuppressant agents and secondary infections in patients with COVID‑19 in intensive care unit: a retrospective study." 41st International Symposium on Intensive Care and Emergency Medicine , Brussels, Belgium, pp.38-39.

@conferencepaper{conferencepaper, author={Zeynep Tuğçe SARIKAYA Et Al. }, title={The usage of the immunosuppressant agents and secondary infections in patients with COVID‑19 in intensive care unit: a retrospective study}, congress name={41st International Symposium on Intensive Care and Emergency Medicine}, city={Brussels}, country={Belgium}, year={2022}, pages={38-39} }